Biotech

All Articles

Vaderis' uncommon blood vessel condition drug reduces nosebleeds

.Vaderis Therapeutics' objective to establish the first medication targeted primarily at a certain r...

Navigator raises $100M to build brand new autoimmune pipeline

.Sat nav Medicines has furnished itself along with $one hundred thousand in series A funds as the yo...

Duality looks for cash for ADC tests as IPO surge spreads to Asia

.China's Duplicity Biotherapeutics has actually submitted (PDF) documents for a Hong Kong IPO, looki...

YolTech sells China civil rights to genetics editing treatment for $29M

.4 months after Chinese genetics editing and enhancing provider YolTech Therapies took its own chole...

Addex supply rises after Indivior provides to $300M for compound

.Indivior is actually getting a small particle allosteric modulator created to treat element use dis...

Molecular Partners fine-tunes AML trial over 'suboptimal visibility'

.Molecular Companions has actually recognized "suboptimal visibility" to its tetra-specific T-cell e...

Despite blended market, a venture capital revival can be coming in Europe: PitchBook

.While the biotech assets performance in Europe has reduced somewhat following a COVID-19 financing ...

8 months after a $213M fundraise, gene editor Tome helps make reduces

.After rearing $213 million in 2023-- some of the year's biggest private biotech rounds-- Tome Biosc...

BioMarin constructs exec group along with biotech vets-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of significant management hirings, firings and a...

Biopharma Q2 VC attacked highest level because '22, while M&ampA slowed

.Financial backing backing right into biopharma cheered $9.2 billion around 215 handle the second fo...